The University of Oklahoma Health Sciences Center (OUHSC) was awarded a Basic Ordering Agreement (BOA) contract by the Bureau of Medicine and Surgery, a Defense agency, with a ceiling value of $0.00. This single-award IDV contract has an ultimate completion date of April 30, 2035. Under this BOA, OUHSC provides a wide range of biomedical research, healthcare, scientific services, and educational programs to multiple federal agencies, including the Department of Veterans Affairs, U.S. Attorney's Offices, Department of the Navy, and National Cancer Institute. The contracted services have encompassed expert witness services, medical equipment procurement, radiopharmaceutical delivery, sequencing services, geriatric quality improvement coaching, and tuition reimbursement programs. Additionally, OUHSC holds an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Cancer Institute for the PREVENT Cancer Preclinical Drug Development Program, valued at approximately $149,995,000, to support preclinical drug development research, including evaluating efficacy and pharmacodynamic biomarkers for potential cancer preventive agents.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 4/24/25 |